Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1831127091
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4190 City Ave, Suite 324
Philadelphia, PA, 19131
Phone (215) 871-1916
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
1,727 services
Medicare patients, 2024
508
Average age 72
Drug cost, 2024
$2.4M
6,208 prescriptions
Company payments, 2025
$11K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Freeman was code 99214 (office e&m - established), 733 times for 355 patients. In total Jeffrey S Freeman billed 1,727 services in 19 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 733 | 355 | $95.48 | $70K |
| 99231 Hospital E&M - Subsequent | Facility | 287 | 83 | $39.78 | $11K |
| 95251 Test - Miscellaneous | Office | 206 | 98 | $27.43 | $5,651 |
| 99222 Hospital E&M - Initial | Facility | 114 | 104 | $104.98 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 96 | 46 | $63.10 | $6,057 |
| 99213 Office E&M - Established | Office | 76 | 64 | $68.81 | $5,230 |
| 99215 Office E&M - Established | Office | 75 | 48 | $143.41 | $11K |
| 99204 Office E&M - New | Office | 49 | 49 | $127.98 | $6,271 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 38 | 35 | $12.93 | $491 |
| 95250 Test - Miscellaneous | Office | 19 | 19 | $121.44 | $2,307 |
By year: 2022 $141K for 1,729 services; 2023 $123K for 1,508 services; 2024 $133K for 1,727 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Freeman prescribed most often to Medicare patients was Levothyroxine Sodium, with 656 prescriptions and refills. In total Jeffrey S Freeman wrote 6,208 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 656 | 1,688 | 188 | $7,873 |
| Metformin Hcl Generic | 297 | 725 | 79 | $2,531 |
| Atorvastatin Calcium Generic | 272 | 729 | 85 | $4,032 |
| Ozempic Semaglutide | 263 | 424 | 58 | $401K |
| Methimazole Generic | 229 | 539 | 57 | $2,077 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 222 | 433 | 68 | $34K |
| Jardiance Empagliflozin | 203 | 451 | 53 | $245K |
| Synthroid Levothyroxine Sodium | 177 | 410 | 42 | $14K |
| Ezetimibe Generic | 158 | 419 | 52 | $4,801 |
| Novolog Flexpen Insulin Aspart | 144 | 300 | 51 | $38K |
| Trulicity Dulaglutide | 137 | 189 | 28 | $214K |
| Rosuvastatin Calcium Generic | 132 | 333 | 43 | $2,054 |
| Glipizide Generic | 124 | 277 | 31 | $1,247 |
| Tresiba Flextouch U-100 Insulin Degludec | 121 | 309 | 38 | $102K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 118 | 325 | 54 | $13K |
Brand drugs: 2,828 claims; generic drugs: 2,913 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Freeman $11K ($11K in general payments such as food, travel and fees) from 31 companies. The largest payer was Novo Nordisk Inc with $9,420.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 20 | $9,420 |
| Mannkind Corporation MNKD | 16 | $413 |
| Amgen Inc. AMGN | 17 | $230 |
| Intra-Sana Laboratories | 10 | $154 |
| Lilly USA, LLC LLY | 8 | $145 |
| Recordati_rare_diseases_inc. | 7 | $136 |
| Astellas Pharma US Inc 4503.T | 5 | $97.29 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $90.47 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $65.34 |
| Sequel Med Tech, LLC | 3 | $62.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.